Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · REGN · as of Jun 8, 2026
Key Statistics
Explore Regeneron Pharmaceuticals, Inc. Data
regn stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 48 · Buy rate: 66.7%
The REGN analyst consensus is Buy, based on ratings from 48 Wall Street analysts over the past 3 months. The average 12-month price target is $843.84, representing +32.79% upside from the current price of $635.45.
Competitors & Peers
regn competitorsREGN
ALNY
ARGX
CI
COR
ELVStock Performance
Full HistoryAbout Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to trea…
what is regeneron pharmaceuticals, inc. · regn stock overview · regeneron pharmaceuticals, inc. company profile · who is regeneron pharmaceuticals, inc. ceo · regn NASDAQ · regeneron pharmaceuticals, inc. headquarters · regeneron pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Regeneron Pharmaceuticals, Inc. (REGN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 2, 1991. As of the latest trading session, REGN stock price is $635.45, with a market capitalization of $65.5B. The stock has returned +22.77% over the past 12 months and -17.67% year-to-date.
According to 48 Wall Street analysts, the consensus rating for Regeneron Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $843.84. In fiscal year 2025, Regeneron Pharmaceuticals, Inc. reported revenue of $14.3B and net income of $4.5B. For detailed data — including Regeneron Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Regeneron Pharmaceuticals, Inc. (REGN) stock price is $635.45. The stock is traded on NASDAQ under the ticker symbol REGN. The 52-week range is $476.49 – $821.11.